Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models

por Zhang, H, Hylander, B L, LeVea, C, Repasky, E A, Straubinger, R M, Adjei, A A, Ma, W W
Publicado 2014